Use of fluoroquinolones in patients with chronic hepatitis C virus-induced liver failure

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 10, 2002, Pages 3280-3282

  Kojima, H ^a   Kaita, K D E ^a   Hawkins, K ^a   Uhanova, J ^a   Minuk, G Y ^a  

^a John Buhler Research Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; LIVER ENZYME; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VIRUS RNA;

ADULT; AGED; ANOREXIA; ANTIBIOTIC THERAPY; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INSOMNIA; LIVER FAILURE; MALE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RNA VIRUS; VIRUS LOAD;

ALANINE TRANSAMINASE; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DOUBLE-BLIND METHOD; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER FAILURE; PROSPECTIVE STUDIES; RNA, VIRAL; TREATMENT OUTCOME;

EID: 0036783716     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.10.3280-3282.2002     Document Type: Article

References (14)

1. Epidemiology of hepatitis C
2. Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: Effect of long-term administration of norfloxacin
3. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C
4. Hepatitis C viral infection in liver transplant recipients
5. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis
6. Antiviral activity and inhibition of topoisomerase by ofloxacin, a new quinolone derivative
7. Pilot study of ofloxacin and interferon-alpha combination therapy for chronic hepatitis C without sustained response to initial interferon administration
8. Pathogenesis, natural history, treatment, and prevention of hepatitis C
9. Treatment of chronic hepatitis C with α-interferon plus ofloxacin in patients not responding to α-interferon alone
10. Fluoroquinolones protect the human lymphocyte CEM cell line from HIV-1-mediated cytotoxicity
11. Inhibition of retrovirus RNA-dependent DNA polymerase by novobiocin and nalidixic acid
12. Effects of ofloxacin for type C hepatitis
13. Effects of combination therapy with interferon and ofloxacin on chronic type C hepatitis: A pilot study
14. Effects of hepatic stimulator substance, herbal medicine, selenium/vitamin E, and ciprofloxacin on cirrhosis in the rat